Cargando…

An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer

Background: Immune cells have essential auxiliary functions and influence clinical outcomes in cancer, with high immune infiltration being associated with improved clinical outcomes and better response to treatment in breast cancer (BC). However, studies to date have not fully considered the tumor-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Silei, An, Xin, Xu, Caiming, Li, Zongjuan, Hua, Yijun, Huang, Geya, Sui, Sibei, Long, Qian, Sui, Yanxia, Xiong, Yuqing, Ntim, Micheal, Guo, Wei, Chen, Miao, Deng, Wuguo, Xiao, Xiangsheng, Li, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667685/
https://www.ncbi.nlm.nih.gov/pubmed/33204321
http://dx.doi.org/10.7150/thno.49451
_version_ 1783610360442388480
author Sui, Silei
An, Xin
Xu, Caiming
Li, Zongjuan
Hua, Yijun
Huang, Geya
Sui, Sibei
Long, Qian
Sui, Yanxia
Xiong, Yuqing
Ntim, Micheal
Guo, Wei
Chen, Miao
Deng, Wuguo
Xiao, Xiangsheng
Li, Man
author_facet Sui, Silei
An, Xin
Xu, Caiming
Li, Zongjuan
Hua, Yijun
Huang, Geya
Sui, Sibei
Long, Qian
Sui, Yanxia
Xiong, Yuqing
Ntim, Micheal
Guo, Wei
Chen, Miao
Deng, Wuguo
Xiao, Xiangsheng
Li, Man
author_sort Sui, Silei
collection PubMed
description Background: Immune cells have essential auxiliary functions and influence clinical outcomes in cancer, with high immune infiltration being associated with improved clinical outcomes and better response to treatment in breast cancer (BC). However, studies to date have not fully considered the tumor-infiltrating immune cell (TIIC) landscape in tumors. This study investigated potential biomarkers based on TIICs to improve prognosis and treatment effect in BC. Results: We enrolled 5112 patients for analysis and used cell type identification by estimating relative subsets of RNA transcripts (CIBERSORT), a new computational algorithm, to quantify 22 TIICs in primary BC. From the results of univariate Cox regression, 12 immune cells were determined to be significantly related to the overall survival (OS) of BC patients. Furthermore, least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses were applied to construct an immune prognostic model based on six potential biomarkers. By dividing patients into low- and high-risk groups, a significant distinction in OS was found in the training cohort, with 20-year survival rates of 42.6% and 26.3%, respectively. Applying a similar protocol to validation and test cohorts, we found that OS was significantly shorter in the high-risk group than in the low-risk group, regardless of the molecular subtype of BC. Using the immune score model to predict the effect of BC patients to chemotherapy, the survival advantage for the low-risk group was evident among those who received chemotherapy, regardless of the chemotherapy regimen. In evaluating the predictive value of the nomogram, a decision curve showed better predictive accuracy than the standard tumor-node-metastasis (TNM) staging system. Conclusion: The immune cell infiltration-based immune score model can be effectively and efficiently used to predict the prognosis of BC patients as well as the effect of chemotherapy.
format Online
Article
Text
id pubmed-7667685
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-76676852020-11-16 An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer Sui, Silei An, Xin Xu, Caiming Li, Zongjuan Hua, Yijun Huang, Geya Sui, Sibei Long, Qian Sui, Yanxia Xiong, Yuqing Ntim, Micheal Guo, Wei Chen, Miao Deng, Wuguo Xiao, Xiangsheng Li, Man Theranostics Research Paper Background: Immune cells have essential auxiliary functions and influence clinical outcomes in cancer, with high immune infiltration being associated with improved clinical outcomes and better response to treatment in breast cancer (BC). However, studies to date have not fully considered the tumor-infiltrating immune cell (TIIC) landscape in tumors. This study investigated potential biomarkers based on TIICs to improve prognosis and treatment effect in BC. Results: We enrolled 5112 patients for analysis and used cell type identification by estimating relative subsets of RNA transcripts (CIBERSORT), a new computational algorithm, to quantify 22 TIICs in primary BC. From the results of univariate Cox regression, 12 immune cells were determined to be significantly related to the overall survival (OS) of BC patients. Furthermore, least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses were applied to construct an immune prognostic model based on six potential biomarkers. By dividing patients into low- and high-risk groups, a significant distinction in OS was found in the training cohort, with 20-year survival rates of 42.6% and 26.3%, respectively. Applying a similar protocol to validation and test cohorts, we found that OS was significantly shorter in the high-risk group than in the low-risk group, regardless of the molecular subtype of BC. Using the immune score model to predict the effect of BC patients to chemotherapy, the survival advantage for the low-risk group was evident among those who received chemotherapy, regardless of the chemotherapy regimen. In evaluating the predictive value of the nomogram, a decision curve showed better predictive accuracy than the standard tumor-node-metastasis (TNM) staging system. Conclusion: The immune cell infiltration-based immune score model can be effectively and efficiently used to predict the prognosis of BC patients as well as the effect of chemotherapy. Ivyspring International Publisher 2020-10-25 /pmc/articles/PMC7667685/ /pubmed/33204321 http://dx.doi.org/10.7150/thno.49451 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Sui, Silei
An, Xin
Xu, Caiming
Li, Zongjuan
Hua, Yijun
Huang, Geya
Sui, Sibei
Long, Qian
Sui, Yanxia
Xiong, Yuqing
Ntim, Micheal
Guo, Wei
Chen, Miao
Deng, Wuguo
Xiao, Xiangsheng
Li, Man
An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
title An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
title_full An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
title_fullStr An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
title_full_unstemmed An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
title_short An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
title_sort immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667685/
https://www.ncbi.nlm.nih.gov/pubmed/33204321
http://dx.doi.org/10.7150/thno.49451
work_keys_str_mv AT suisilei animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT anxin animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT xucaiming animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT lizongjuan animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT huayijun animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT huanggeya animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT suisibei animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT longqian animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT suiyanxia animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT xiongyuqing animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT ntimmicheal animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT guowei animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT chenmiao animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT dengwuguo animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT xiaoxiangsheng animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT liman animmunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT suisilei immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT anxin immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT xucaiming immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT lizongjuan immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT huayijun immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT huanggeya immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT suisibei immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT longqian immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT suiyanxia immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT xiongyuqing immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT ntimmicheal immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT guowei immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT chenmiao immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT dengwuguo immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT xiaoxiangsheng immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer
AT liman immunecellinfiltrationbasedimmunescoremodelpredictsprognosisandchemotherapyeffectsinbreastcancer